
### [MONDO:0000628](http://purl.obolibrary.org/obo/MONDO_0000628)
**Label:** central nervous system organ benign neoplasm

**Subclasses:** [MONDO:0021439](http://purl.obolibrary.org/obo/MONDO_0021439) (benign neoplasm of pituitary gland), [MONDO:0015196](http://purl.obolibrary.org/obo/MONDO_0015196) (vein of Galen aneurysm), [MONDO:0003844](http://purl.obolibrary.org/obo/MONDO_0003844) (central nervous system lipoma), [MONDO:0003845](http://purl.obolibrary.org/obo/MONDO_0003845) (corpus callosum lipoma), [MONDO:0002712](http://purl.obolibrary.org/obo/MONDO_0002712) (epidural spinal canal angiolipoma), [MONDO:0003843](http://purl.obolibrary.org/obo/MONDO_0003843) (cerebral hemisphere lipoma), [MONDO:0009837](http://purl.obolibrary.org/obo/MONDO_0009837) (choroid plexus papilloma), [MONDO:0006634](http://purl.obolibrary.org/obo/MONDO_0006634) (pituitary gland acidophil adenoma), [MONDO:0006238](http://purl.obolibrary.org/obo/MONDO_0006238) (growth hormone-producing pituitary gland adenoma), [MONDO:0003241](http://purl.obolibrary.org/obo/MONDO_0003241) (central nervous system hemangioma), [MONDO:0004133](http://purl.obolibrary.org/obo/MONDO_0004133) (pituitary gland mixed eosinophil-basophil adenoma), [MONDO:0006673](http://purl.obolibrary.org/obo/MONDO_0006673) (pituitary gland basophil adenoma), [MONDO:0003287](http://purl.obolibrary.org/obo/MONDO_0003287) (central nervous system leiomyoma), [MONDO:0018907](http://purl.obolibrary.org/obo/MONDO_0018907) (craniopharyngioma), [MONDO:0016723](http://purl.obolibrary.org/obo/MONDO_0016723) (pineocytoma (disease)), [MONDO:0021506](http://purl.obolibrary.org/obo/MONDO_0021506) (benign neoplasm of spinal cord), [MONDO:0010492](http://purl.obolibrary.org/obo/MONDO_0010492) (pituitary adenoma, growth hormone-secreting, 2), [MONDO:0021507](http://purl.obolibrary.org/obo/MONDO_0021507) (benign neoplasm of brain stem), [MONDO:0016035](http://purl.obolibrary.org/obo/MONDO_0016035) (Nelson syndrome), [MONDO:0000821](http://purl.obolibrary.org/obo/MONDO_0000821) (cerebral cavernous malformation 3), [MONDO:0002328](http://purl.obolibrary.org/obo/MONDO_0002328) (intracranial hemangioma), [MONDO:0002327](http://purl.obolibrary.org/obo/MONDO_0002327) (intracranial cavernous angioma), [MONDO:0000820](http://purl.obolibrary.org/obo/MONDO_0000820) (cerebral cavernous malformation), [MONDO:0003054](http://purl.obolibrary.org/obo/MONDO_0003054) (benign meningioma), [MONDO:0001790](http://purl.obolibrary.org/obo/MONDO_0001790) (spinal cord lipoma), [MONDO:0007052](http://purl.obolibrary.org/obo/MONDO_0007052) (growth hormone secreting pituitary adenoma), [MONDO:0011305](http://purl.obolibrary.org/obo/MONDO_0011305) (cerebral cavernous malformations 3), [MONDO:0007291](http://purl.obolibrary.org/obo/MONDO_0007291) (familial cerebral cavernous malformation), [MONDO:0011304](http://purl.obolibrary.org/obo/MONDO_0011304) (cerebral cavernous malformation 2), [MONDO:0019933](http://purl.obolibrary.org/obo/MONDO_0019933) (acromegaly), [MONDO:0019612](http://purl.obolibrary.org/obo/MONDO_0019612) (functioning gonadotropic adenoma), [MONDO:0019613](http://purl.obolibrary.org/obo/MONDO_0019613) (non-functioning pituitary adenoma), [MONDO:0019611](http://purl.obolibrary.org/obo/MONDO_0019611) (TSH-secreting pituitary adenoma), [MONDO:0003828](http://purl.obolibrary.org/obo/MONDO_0003828) (growth hormone-producing pituitary gland carcinoma), [MONDO:0003948](http://purl.obolibrary.org/obo/MONDO_0003948) (cerebral hemangioma), [MONDO:0021497](http://purl.obolibrary.org/obo/MONDO_0021497) (benign neoplasm of cerebrum), [MONDO:0003428](http://purl.obolibrary.org/obo/MONDO_0003428) (brain hemangioma), [MONDO:0003901](http://purl.obolibrary.org/obo/MONDO_0003901) (cerebellar hemangioblastoma), [MONDO:0021499](http://purl.obolibrary.org/obo/MONDO_0021499) (benign neoplasm of cerebellum), [MONDO:0003429](http://purl.obolibrary.org/obo/MONDO_0003429) (functioning pituitary gland adenoma), [MONDO:0003902](http://purl.obolibrary.org/obo/MONDO_0003902) (brain stem hemangioblastoma), [MONDO:0003943](http://purl.obolibrary.org/obo/MONDO_0003943) (central nervous system hibernoma), [MONDO:0021451](http://purl.obolibrary.org/obo/MONDO_0021451) (benign neoplasm of brain), [MONDO:0006373](http://purl.obolibrary.org/obo/MONDO_0006373) (pituitary gland adenoma), [MONDO:0021527](http://purl.obolibrary.org/obo/MONDO_0021527) (benign neoplasm of meninges), [MONDO:0017822](http://purl.obolibrary.org/obo/MONDO_0017822) (mixed functioning pituitary adenoma), [MONDO:0003837](http://purl.obolibrary.org/obo/MONDO_0003837) (TSH producing pituitary tumor), [MONDO:0003836](http://purl.obolibrary.org/obo/MONDO_0003836) (malignant thyroid stimulating hormone producing neoplasm of pituitary gland), [MONDO:0002787](http://purl.obolibrary.org/obo/MONDO_0002787) (adamantinous craniopharyngioma), [MONDO:0020479](http://purl.obolibrary.org/obo/MONDO_0020479) (pituitary gigantism), [MONDO:0002788](http://purl.obolibrary.org/obo/MONDO_0002788) (papillary craniopharyngioma), [MONDO:0006701](http://purl.obolibrary.org/obo/MONDO_0006701) (chromophobe adenoma), [MONDO:0006068](http://purl.obolibrary.org/obo/MONDO_0006068) (ACTH-producing pituitary gland adenoma), [MONDO:0007154](http://purl.obolibrary.org/obo/MONDO_0007154) (arteriovenous malformations of the brain), [MONDO:0017824](http://purl.obolibrary.org/obo/MONDO_0017824) (familial isolated pituitary adenoma), [MONDO:0010911](http://purl.obolibrary.org/obo/MONDO_0010911) (prolactin-producing pituitary gland adenoma), [MONDO:0019927](http://purl.obolibrary.org/obo/MONDO_0019927) (growth hormone-producing pituitary gland neoplasm), [MONDO:0017823](http://purl.obolibrary.org/obo/MONDO_0017823) (Somatomammotropinoma), [MONDO:0017826](http://purl.obolibrary.org/obo/MONDO_0017826) (null pituitary adenoma), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0017825](http://purl.obolibrary.org/obo/MONDO_0017825) (silent pituitary adenoma), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0009948](http://purl.obolibrary.org/obo/GO_0009948) (anterior/posterior axis specification), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:2000352](http://purl.obolibrary.org/obo/GO_2000352) (negative regulation of endothelial cell apoptotic process), [GO:2000114](http://purl.obolibrary.org/obo/GO_2000114) (regulation of establishment of cell polarity), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001885](http://purl.obolibrary.org/obo/GO_0001885) (endothelial cell development), [GO:0001886](http://purl.obolibrary.org/obo/GO_0001886) (endothelial cell morphogenesis), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0045602](http://purl.obolibrary.org/obo/GO_0045602) (negative regulation of endothelial cell differentiation), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0048845](http://purl.obolibrary.org/obo/GO_0048845) (venous blood vessel morphogenesis), [GO:0045454](http://purl.obolibrary.org/obo/GO_0045454) (cell redox homeostasis), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0060039](http://purl.obolibrary.org/obo/GO_0060039) (pericardium development), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0030695](http://purl.obolibrary.org/obo/GO_0030695) (GTPase regulator activity), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0007033](http://purl.obolibrary.org/obo/GO_0007033) (vacuole organization), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0061154](http://purl.obolibrary.org/obo/GO_0061154) (endothelial tube morphogenesis), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0005138](http://purl.obolibrary.org/obo/GO_0005138) (interleukin-6 receptor binding), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0007043](http://purl.obolibrary.org/obo/GO_0007043) (cell-cell junction assembly), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0072554](http://purl.obolibrary.org/obo/GO_0072554) (blood vessel lumenization), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), 

**Class expressions from DL-Learner:**

- Thing 53.94%
- [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding) 51.32%
- [GO:0051429](http://purl.obolibrary.org/obo/GO_0051429) (corticotropin-releasing hormone receptor binding) 51.32%
- [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding) 51.32%
- [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma) 51.32%
- [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding) 51.32%
- [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding) 51.32%
- [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding) 51.32%
- [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding) 51.32%
- [GO:0031690](http://purl.obolibrary.org/obo/GO_0031690) (adrenergic receptor binding) 51.32%
- [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding) 51.32%
- [GO:0031628](http://purl.obolibrary.org/obo/GO_0031628) (opioid receptor binding) 51.32%
- [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex) 51.32%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 51.32%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.32%


